Peter M. Wehmeier
Bad Homburg Vor Der Hoehe, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: November 17, 2010
Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials.
Journal: Child and adolescent psychiatry and mental health
Published: June 23, 2010
Minor differences in ADHD-related difficulties between boys and girls treated with atomoxetine for attention-deficit/hyperactivity disorder.
Journal: Attention deficit and hyperactivity disorders
Published: August 19, 2009
Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life.
Journal: The Journal of adolescent health : official publication of the Society for Adolescent Medicine
Published: March 25, 2009
Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years.
Journal: Child and adolescent psychiatry and mental health
Published: November 18, 2008
Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies.
Journal: Child and adolescent psychiatry and mental health
Published: November 18, 2008
Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label study.
Journal: Journal of child and adolescent psychopharmacology
Published: March 05, 2008
Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS).
Journal: Child and adolescent psychiatry and mental health
Published: February 27, 2008
Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day.
Journal: Child and adolescent psychiatry and mental health
Published: January 23, 2008
Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
Journal: Journal of psychiatric research
Published: March 08, 2007
Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
Journal: Schizophrenia research
Published: October 18, 2006
Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: September 13, 2006
Showing 1-12 of 12
Last Updated: 09/26/2026